Drug profile · INN
eprosartan
TEVETEN
eprosartan (TEVETEN) is a type-1 angiotensin ii receptor antagonist. Associated with Viatris Pharmaceuticals Co.,.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — eprosartan
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
eprosartan (TEVETEN) is a type-1 angiotensin ii receptor antagonist. Associated with Viatris Pharmaceuticals Co.,.
Key facts
INN eprosartan
Brand TEVETEN
Mechanism Type-1 angiotensin II receptor antagonist
Originator Viatris Pharmaceuticals Co.,
Mechanism of action
Type-1 angiotensin II receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is eprosartan?
eprosartan (TEVETEN) is a type-1 angiotensin ii receptor antagonist. Associated with Viatris Pharmaceuticals Co.,.
What is the brand name for eprosartan?
TEVETEN is a marketed brand name for eprosartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.